Author pages are created from data sourced from our academic publisher partnerships and public sources.
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
- P. Anagnostis, V. Athyros, K. Tziomalos, A. Karagiannis, D. Mikhailidis
- The Journal of clinical endocrinology and…
- 1 August 2009
CONTEXT The metabolic syndrome (MetS) is a cluster of metabolic abnormalities that increase the risk for type 2 diabetes mellitus and vascular disease. The common characteristics of MetS and… Expand
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
- V. Athyros, D. Mikhailidis, +7 authors M. Elisaf
- Current medical research and opinion
- 4 April 2006
ABSTRACT Background: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). There is no established treatment for NAFLD. Aim: To evaluate a… Expand
Pheochromocytoma: an update on genetics and management.
- A. Karagiannis, D. Mikhailidis, V. Athyros, F. Harsoulis
- Endocrine-related cancer
- 1 December 2007
Pheochromocytomas (PHEOs) are rare neoplasms that produce catecholamines and usually arise from the adrenal medulla and are considered to be an adrenal paraganglioma (PGL). Closely related tumors of… Expand
Gonadal dysfunction in systemic diseases.
Gonadal function is significantly affected in many acute and chronic systemic diseases. As the function of the testes and the ovaries is determined by the integrity of the… Expand
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
- V. Athyros, K. Tziomalos, N. Katsiki, M. Doumas, A. Karagiannis, D. Mikhailidis
- World journal of gastroenterology
- 14 June 2015
Non-alcoholic fatty liver disease (NAFLD) is considered to be an independent cardiovascular disease (CVD) risk factor. However, simple steatosis has a benign clinical course without excess mortality.… Expand
Should adipokines be considered in the choice of the treatment of obesity-related health problems?
- V. Athyros, K. Tziomalos, A. Karagiannis, P. Anagnostis, D. Mikhailidis
- Current drug targets
White adipose tissue (WAT) is an important endocrine organ that secretes approximately 30 biologically active peptides and proteins, collectively termed "adipokines". These are either produced… Expand
Contrast-induced nephropathy (CIN) represents an important adverse effect of contrast media (CM) administration. Contrast-induced nephropathy is associated with prolonged hospitalization as well as… Expand
Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort
The purpose of this study was to investigate the relationship between alcohol consumption and the prevalence of the metabolic syndrome (MetS), type 2 diabetes mellitus (DM), coronary heart disease… Expand
Serum uric acid as an independent predictor of early death after acute stroke.
- A. Karagiannis, D. Mikhailidis, +8 authors V. G. Athyros
- Circulation journal : official journal of the…
- 20 June 2007
BACKGROUND The prognostic significance of uric acid (UA) levels in acute stroke is unclear, so the objective of this study was to determine the association between levels of serum UA (SUA) and… Expand
Angiotensin II reactivation and aldosterone escape phenomena in renin–angiotensin–aldosterone system blockade: is oral renin inhibition the solution?
- V. Athyros, D. Mikhailidis, A. Kakafika, K. Tziomalos, A. Karagiannis
- Expert opinion on pharmacotherapy
- 22 March 2007
This editorial considers the use of the first selective oral renin inhibitor, aliskiren, in reducing angiotensin (Ang) II reactivation or aldosterone (ALDO) escape during… Expand